Immunexpress Inc.
Seattle, WA
- UEI
- KYM8QF1NW567
- CAGE
- 659L3
- Primary NAICS
- 325413 In-Vitro Diagnostic Substance Manufacturing
- SAM.gov registration
- Expired
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 425 Pontius Ave N #470, Seattle, WA 98109, USA
- Website
- immunexpress.com
- Founded
- 2006
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract awards
Quick answers
Is Immunexpress Inc. registered in SAM.gov?
Immunexpress Inc.'s SAM.gov registration expired on September 8, 2026.
What is Immunexpress Inc.'s CAGE code?
Immunexpress Inc.'s CAGE code is 659L3, and its Unique Entity ID (UEI) is KYM8QF1NW567.
What is Immunexpress Inc.'s most recent federal award?
Immunexpress Inc.'s most recent federal contract award is Immunexpress assessment & triage of patients with escalating signs of covid-19 disease using a host response test for… (75A50120C00125), from Office of the Assistant Secretary for Preparedness and Response, on June 11, 2020.
On GovTribe
See Immunexpress Inc.'s full federal record
- Federal contract awards
- IDV awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors